Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Iron and Folic Acid in Arsenicosis
NCT02908581Phase 2Completed
- Sponsor
- Bangabandhu Sheikh Mujib Medical University
- Start
- Jun 2016
- Primary completion
- Apr 2017
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of ferrous sulfate and folic acid in arsenic poisoning (2 arms), sponsored by Bangabandhu Sheikh Mujib Medical University. Primary endpoint: Changes in the type of fungus in skin surface at 12 weeks. Started Jun 2016; status: completed.
02
Drugs
ferrous sulfatefolic acid
03
Conditions
arsenic poisoning
Beyond the preview
Go deeper on NCT02908581.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02908581.